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Abstract
Background
Elevated levels of C-reactive protein (CRP, determined by a high-sensitivity assay) indicate
low-grade inflammation which is implicated in many age-related disorders. Epigenetic stud-
ies on CRP might discover molecular mechanisms underlying CRP regulation. We aimed
to identify DNA methylation sites related to CRP concentrations in cells and tissues regulat-
ing low-grade inflammation.
Results
Genome-wide DNA methylation was measured in peripheral blood in 1,741 participants of
the KORA F4 study using Illumina HumanMethylation450 BeadChip arrays. Four CpG
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sites (located at BCL3, AQP3, SOCS3, and cg19821297 intergenic at chromosome
19p13.2, P 1.01E-07) were significantly hypomethylated at high CRP concentrations
independent of various confounders including age, sex, BMI, smoking, and white blood cell
composition. Findings were not sex-specific. CRP-related top genes were enriched in JAK/
STAT pathways (Benjamini-Hochberg corrected P < 0.05). Results were followed-up in
three studies using DNA from peripheral blood (EPICOR, n = 503) and adipose tissue
(TwinsUK, n = 368) measured as described above and from liver tissue (LMU liver cohort, n
= 286) measured by MALDI-TOF mass spectrometry using EpiTYPER. CpG sites at the
AQP3 locus (significant p-values in peripheral blood = 1.72E-03 and liver tissue = 1.51E-
03) and the SOCS3 locus (p-values in liver < 2.82E-05) were associated with CRP in the
validation panels.
Conclusions
Epigenetic modifications seem to engage in low-grade inflammation, possibly via JAK/
STAT mediated pathways. Results suggest a shared relevance across different tissues at
the AQP3 locus and highlight a role of DNA methylation for CRP regulation at the SOCS3
locus.
Introduction
Low-grade inflammation is thought to induce, promote or more generally influence human
susceptibility to many age-related disorders such as coronary heart disease[1], type 2 diabetes
[2], and several malignancies[3].Modestly elevated concentrations of C-reactive protein
(CRP), measured by a high-sensitivity assay, are a sensitive marker of low-grade inflammation.
CRP is released into the systemic circulation in response to inflammatory stimuli as the final
product of various inflammatory pathways. As an acute-phase reactant it is predominantly
synthesized by hepatocytes and regulated via the transcription factors STAT3, C/EBP family
members and NF-kappaB by the pro-inflammatory cytokines IL-6 and IL-1ß[4,5]. To a minor
degree, extra-hepatic expression has been reported for adipose tissue and blood cells[5]. Sys-
temic levels of CRP are known to be influenced by age, sex, environmental and life style condi-
tions like smoking exposure and BMI as well as genetic determinants with substantial
heritability estimates[6]. Recent research focusing on common sequence variants has only par-
tially explained the molecular basis of systematically circulating CRP[7].
Epigenetic modifications such as changes in DNA methylation seem to have important reg-
ulatory functions in cellular processes[8], including inflammatory responses of the human
body[9]. Previous studies suggested that non-genetic determinants of CRP like age[10–12], sex
[13,14], diet[15] and exposure to cigarette smoking[16] as well as genetic factors[17,18] are
associated with epigenetic modification. In addition, evidence indicated that epigeneticmecha-
nisms are implicated in the development of several malignancies[19] as well as atherosclerosis
[20] which are both characterized by aberrant inflammatory processes[21,22]. Finally, epige-
netic modificationswere observed in several inflammatory disease states[23–27]. Therefore,
epigenetic modifications integrating both environmental as well as genetic factors might rele-
vantly engage in low-grade inflammation as reflected by elevated levels of circulating CRP.
Epigenome-wide association studies (EWAS) on DNA methylation hold the potential to
identify epigenetic modifications of CRP regulation across the genome. This could provide
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important clues to immune response pathways involved in the regulation of low-grade inflam-
mation and might also be of relevance for related clinical entities. Therefore, we conducted an
EWAS on CRP concentrations in a large population-based study using DNA methylation data
in peripheral blood. To validate and to assess tissue specificity and relevance of the discovery
findings, results were followed up in three independent studies using DNA methylation data
derived from peripheral blood, adipose and liver tissue. In addition, gene expression panels for
validated genes were generated, transcript levels of these genes were quantified in human liver
samples, and enrichment analyses were conducted to ascertain functional properties of identi-
fied loci.
Results
Discovery of DNA methylation sites related to CRP in peripheral blood
We observed epigenome-wide significant associations with systemic CRP concentrations for 4
CpG sites located intronic at B-cell lymphoma 3 (BCL3), and aquaporin 3 (AQP3), in exon 2 at
Suppressor of cytokine signaling (SOCS3), and intergenic (12kb upstream of jun B proto-onco-
gene, JUNB) at chromosome 19p13.2 in the comprehensive model (p-values range 6.14E-10–
1.01E-07, Table 1, Fig 1). There was an inverse association betweenDNA methylation and lev-
els of CRP for all significant CpG sites with effects ranging from -0.023 to -0.031.
No statistically significant interaction term betweenmethylation beta values of the 4 signifi-
cant CpG sites and sex was observed (data not shown).
We identified correlations 0.8 with SNPs (listed in Table A in S1 File) for two CpG sites
(cg26470501 and cg19821297). Associations remained similar when we repeated the analyses
for these two loci with additional adjustment for correlated SNPs in participants of the KORA
F4 study where genomic and DNA methylation data were available (Table A in S1 File). Like-
wise, associations remained within similar ranges when we repeated the analyses with addi-
tional adjustments for lipids, uric acid, leptin, fasting glucose, alcohol consumption, systolic
blood pressure, or medication (Table A in S1 File).
Enrichment analysis
All unique genes identified in the EWAS at a 5% false discovery rate significance level (23
genes, File A and Table B in S1 File) were annotated in the Ingenuity Pathway Analysis (IPA)
database. The enrichment analysis yielded 6 statistically significant canonical pathways with
Benjamini-Hochberg corrected p-values< 0.05 (Table 2).
Replication of significant loci in peripheral blood
One of the four significant CpG sites (cg02716826 at AQP3) was confirmed in the EPICOR
peripheral blood cohort with the effect estimate being consistent with the one of the discovery
analysis in direction and magnitude of effect (Table 1). The CpG site cg02716826 remained sta-
tistically significant after further adjustment for myocardial infarction case-control status (ß
coefficient= -0.035, se = 0.011, p = 2.13E-3).
Validation of significant loci in adipose tissue and in liver samples
In the TwinsUK study, associations were consistent with those of the discovery analysis in
direction and magnitude of effects but p-values were not statistically significant (Table 1).
In the LMU liver cohort, CpG sites representing 2 of the discovery loci (AQP3 and SOCS3)
yielded statistically significant results in the validation analyses (Table 1). At the AQP3 locus
the discoveryCpG site cg02716826 was significantly associated with CRP. At the SOCS3 locus
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the discoveryCpG site cg18181703 was not associated with CRP but adjacent CpG sites which
were significantly correlated with the discoveryCpG site (Spearman’s rank correlation coeffi-
cients = 0.48 and 0.52 for CpG_2.3 and CpG_8.9, respectively, each with P = 2.2E-16) yielded
statistically significant associations. A full table of results of the LMU liver cohort is presented
in Table C in S1 File.
Results of gene expression analyses
In the gene expression panels, both genes,AQP3 and SOCS3, were expressed not only in blood
cells but also to different degrees in human tissues (Fig A in S1 File). While AQP3 was mainly
expressed in kidney, lung, heart, and liver tissue, SOCS3displayed highest gene activity in heart
and adipose tissue.
In the LMU liver cohort, gene expression levels of SOCS3were significantly correlated with
CRP concentrations (Spearman’s rank correlation coefficient= 0.15, P = 0.01) but not with
Table 1. Significant associations between CRP and DNA methylation sites in the discovery and validation panels.
Locus KORA F4 EPICOR TwinsUK LMU liver cohort
Gene chr CpG ß coef se p ß coef se p ß coef se p ß coef se p
BCL3 19 cg26470501 -0.03 0.005 6.14E-10 -0.02 0.013 1.21E-01 -0.02 0.01 3.12E-01 -0.01 0.01 3.24E-01
AQP3 9 cg02716826 -0.03 0.005 2.72E-08 -0.04 0.011 1.72E-03 -0.02 0.01 2.44E-01 0.04 0.01 1.51E-03
NA* 19 cg19821297 -0.02 0.004 5.19E-08 -0.02 0.01 6.56E-02 -0.001 0.01 9.01E-01 -0.02 0.01 8.62E-03
SOCS3 17 cg18181703 -0.02 0.004 1.01E-07 -0.01 0.011 1.89E-01 -0.01 0.01 4.27E-01 -0.01 0.01 1.12E-01
SOCS3 17 CpG_2.3 NA NA NA NA NA NA NA NA NA -0.04 0.01 4.36E-07
SOCS3 17 CpG_8.9 NA NA NA NA NA NA NA NA NA -0.03 0.01 2.82E-05
Significant associations between ln-transformed systemic CRP levels and beta values of DNA methylation sites were assessed using multivariate linear
mixed effects models in KORA F4 (n = 1741), EPICOR (n = 503), and TwinsUK (n = 286) and multivariate linear models in the LMU liver cohort (n = 286)
adjusting for various confounding variables and correcting for multiple testing according to Bonferroni. Significant p-values (1.13E-07, 1.25E-02, and 1.92E-
03 in KORA F4, EPICOR and TwinsUK and the LMU liver cohort, respectively) are marked in bold font. chr: chromosome; Gene: UCSC reference gene
according to USCS Genome Browser; ß coef: β coefficient; se: standard error
*no gene annotation for this CpG site according to the UCSC Genome Browser.
doi:10.1371/journal.pone.0166015.t001
Fig 1. Manhattan Plot of the results of the genome-wide DNA methylation analysis on CRP conducted in the KORA F4 discovery
sample. The Manhattan plot displays all analyzed CpG sites with their calculated p-values. Threshold of epigenome-wide significance: P = 1.13E-
07.
doi:10.1371/journal.pone.0166015.g001
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cg18181703 or any other CpG site covered by the corresponding amplicon (data not shown).
Gene expression levels of AQP3 were not correlated with CRP concentrations but displayed a
significant correlation with CpG_5 of the corresponding amplicon (Spearman’s rank correla-
tion coefficient= -0.14, P = 0.01).
Discussion
In this study we report key findings from an epigenetic study on low-grade inflammation as
reflected by concentrations of CRP in cells and tissues regulating low-grade inflammation.
DNA methylation sites were associated with CRP in peripheral blood
independent of other risk factors
In a first step, we conducted an EWAS in a large population-based study and identified four
loci at chromosomes 9, 17 and 19 inversely associated with concentrations of CRP. A lower
degree of DNA methylation at some CpG sites was also observed in conditions related to ele-
vated levels of CRP such as older age[12], adiposity[28], and smoking[16,29,30].However, in
the present study the association was independent of various CRP determinants including age,
sex, BMI, and cigarette smoking. A general inverse association is consistent with findings of a
previous EWAS conducted in hypertensive African Americans using DNA methylation data
derived from leucocytes[31].
Functional properties of inflammation-related epigenetic signatures in
peripheral blood
Six statistically significant pathways were identified in enrichment analyses including top CRP
related genes identified in the EWAS. Janus kinase (JAK)/ Signal Transducer and Activator of
Transcription (STAT) signaling plays a major role in almost all of these pathways. The highly
conserved JAK/STAT signaling pathway is part of the orchestrated cascade during the acute-
phase response transmitting extra-cellular signals through the cell membrane into gene pro-
moters[32]. Thereby, it modulates transcription of genes like the acute-phase proteins fibrino-
gen, serum amyloid A, and CRP which are all responsive to STAT3. The importance of JAK/
STAT signaling in the regulation of the immune system was further highlighted by studies
reporting immune deficiency syndromes following disruption or dysregulation of JAK/STAT
functionality[33]. Thus, from a biological perspective a conceivable mechanism via JAK/STAT
signaling seems to be plausible.
Table 2. Significant canonical pathways in the KOFA F4 discovery panel.
Canonical pathways Benjamini-Hochberg p-value Genes
Role of JAK2 in Hormone-like Cytokine Signaling 0.02 SOCS3, SH2B2
IL-9 Signaling 0.02 SOCS3, BCL3
Role of JAK1 and JAK3 in Cytokine Signaling 0.04 SOCS3, SH2B2
Growth Hormone Signaling 0.04 SOCS3,
RPS6KA2
Acute Myeloid Leukemia Signaling 0.04 RARA, PIM2
Melanocyte Development and Pigmentation
Signaling
0.04 RPS6KA2, SH2B2
doi:10.1371/journal.pone.0166015.t002
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DNA methylation signatures at AQP3 and SOCS3 were associated with
CRP across different tissues
In order to validate the discovery findings as well as to assess whether the identified epigenetic
effects are specific or shared across different tissues relevant for CRP expression results were
followed up in three independent studies using DNA methylation data derived from peripheral
blood, liver and adipose tissues. In these tissue-specific analyses we found significant associa-
tions at two loci,AQP3 and SOCS3. Both genes seem to be active in different human tissues
according to our gene expression panels.
At the AQP3 locus, associations betweenDNA methylation and CRP were statistically
significant in peripheral blood and liver tissue. In addition, we observed a significant corre-
lation betweenDNA methylation at AQP3 and AQP3 transcript levels in human liver sam-
ples. Main functions of the aquaporin 3 protein are the transport of water, glycerol and
small solutes such as urea and glycerol across the plasma membrane but it also seems to be
involved in functions related to the immune system like wound healing[34] and the activa-
tion of the skin immune system at birth[35]. Furthermore, an up-regulation of AQP3 was
observed under chronic inflammatory conditions such as present in periodontitis[36] and
gastritis[37]. Interestingly, at cg02716826 which was measured in all four studies CRP
effects were negative in the peripheral blood samples as well as in adipose tissue while they
were positive in liver tissue. A complex and tissue specific relationship was also observed in
different cell line studies investigating AQP3 expression in response to cytokine signaling. In
one of these studies, using gingival epithelial cells gene expression was increased in response
to TNF-alpha[36] while other studies report decreased expression levels in response to
TNF-alpha in keratinocytes[38,39].Our study seems to confirm tissue specific effects at this
locus. However, as BMI or other measures of adiposity were not available in the liver study,
we cannot exclude that effect differences might be caused by confounding. Hence, epigenetic
mechanisms at the AQP3 locus seem to have a shared relevance in low-grade inflammation
across different tissues, but further studies are warranted to evaluate tissue specificity of
effects and the influence of adiposity in liver tissue.
The second region at SOCS3was significantly associated with systemic levels of CRP in the
peripheral blood discovery analysis as well as in the liver samples. Furthermore, SOCS3 tran-
script levels were significantly correlated with CRP in human liver tissue. SOCS3 is a negative
feedback regulator of cytokine signaling along the JAK/STAT pathway. Growing evidence sup-
ports a role of epigenetic mechanisms at SOCS3 in several cancers including liver, lung, pancre-
atic and prostate cancer, as well as other malignancies[40–45].Given well confirmed evidence
of the presence of inflammatory cells in tumor microenvironment[3,21] our finding supports a
role of epigeneticmechanisms at SOCS3 in conditions related to inflammation and suggests a
novel link betweenDNA methylation at SOCS3 and systemic CRP in tissues in which immune
mediators are expressed.
As the approach taken in this study is observational in nature it is not possible to draw
causal inferences. Therefore, it might be possible that not the genes themselves, but small regu-
latory elements might engage in the identified associations between epigenetic modifications
and CRP regulation. This is most likely the case as there has been evidence of regulatory ele-
ments like relevant transcription factor binding sites such as C/EBP and NF-kappaB as well as
STAT3 in the AQP3 and the SOCS3 region, respectively (http://genome.ucsc.edu).The identifi-
cation of causal inferences and molecular pathways underlying the relation betweenCpG sites
and CRP levels represents promising targets for future functional studies.
Epigenetic Profiles of CRP in Various Tissues
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Limitations and strengths
Two limitations of our study have to be mentioned. Firstly, epigenetic modifications are cell-
type specific and peripheral blood constitutes a heterogeneous admixture of different cell popu-
lations. Observed changes in DNA methylation profiles might therefore reflect a differential
representation of the cell types in the sample leading to false positive results[46]. However, for
low-grade inflammation peripheral blood is a tissue of interest and a valuable source of infor-
mation. Therefore, we used peripheral blood derivedDNA methylation data in the discovery
sample and in one of the validation samples. In addition, to diminish the risk of cell type con-
founding we adjusting the peripheral blood analyses for white blood cell composition estimated
using algorithms developed on the basis of cell-type specificDNA methylation markers identi-
fied from cell-sorted reference profiles of specific cell populations[47]. Secondly, validation
studies exhibited moderate sample sizes as well as differences in study design or availability of
adjustment variables. In particular, further studies are warranted to investigate the effect of
BMI on DNA methylation in liver tissue and epigenetic modifications in male adipose tissue.
However, the present study had enough power to identify novel epigenetic patterns related to
low-grade inflammation with a shared relevance across different tissue. Findings were plausible
from a biologic perspective, and may promote future research on the regulation of low-grade
inflammation and mechanisms contributing to related clinical disorders. The identified epige-
netic patterns may be used not only in functional studies to provide further insights into molec-
ular mechanisms of inflammatory processes but also in biomarker studies using whole blood to
improve the prediction of inflammation related clinical disorders or events. In addition, gene
expression panels suggest further tissues which seem to be relevant for the identified genes and
promising for in-depth investigations with respect to clinical disorders affecting these tissues.
Thereby, the identified epigenetic loci might present useful targets for the prevention and / or
treatment of these diseases.
Conclusions
Using an epigenetic approach with DNA derived from different trait targeted tissues the pres-
ent study identified epigenetic loci which seem to engage in low-grade inflammation indepen-
dent of various confounders and conceivably via JAK/STAT signaling. In addition, validation
results suggest novel evidence for an epigenetic mode at AQP3 with possible tissue specific
effects but a shared relevance for CRP regulation and extend previous evidence of the impor-
tance of epigeneticmodifications at SOCS3with respect to inflammatory processes.
Materials and Methods
Study design
The present study incorporated data from four different studies and followed a two-stage
design (Fig 2). In the discovery step, we assessed the association betweenCRP and the degree
of DNA methylation using peripheral blood from 1,741 participants of the population-based
CooperativeHealth Research in the Region of Augsburg (KORA) F4 study. Subsequent follow-
up of results was performed in three independent validation panels: the cardiovascular section
of the Italian European Prospective Investigation into Cancer and Nutrition cohort (EPICOR,
n = 503), the TwinsUK cohort (TwinsUK, n = 368 female participants), and a cohort from the
Ludwig-Maximilians-University Munich (LMU liver cohort, n = 286) using DNA methylation
data derived from peripheral blood, adipose, and liver tissue, respectively. For the present
study, subjects with elevated levels of CRP indicating acute infection (CRP> 10 mg/L) and/ or
missing data on CRP were excluded. All studies were approved by the local ethics committees.
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In detail, the KORA study and the LMU study were approved by the Ethics Committee of the
Bavarian Medical Association (Bayerische Landesärztekammer); the EPICOR study was
approved by the Ethical Committee of the Human Genetics Foundation (Turin, Italy); and the
TwinsUK study has ethical approval from the Guy’s and St Thomas’ (GSTT) Ethics Commit-
tee. Written informed consent was obtained from all participants. Study populations are
described in File B in S1 File. Baseline characteristics of participants of the four studies are pro-
vided in Table 3.
Measurement of CRP
CRP was measured in all four studies using high-sensitivity tests (File C in S1 File). The intra-
and inter-assay coefficients of variation were below 6% in all four studies.
Assessment of DNA methylation data
Genome-wideDNA methylation in KORA F4, EPICOR, and TwinsUK was assessed using the
Illumina HumanMethylation450 BeadChip. In brief, genomic data was bisulfite converted.
Subsequently, the bisulfite converted samples were amplified and after enzymatic
Fig 2. Outline of the present study.
doi:10.1371/journal.pone.0166015.g002
Table 3. Baseline characteristics of study participants.
KORA F4 EPICOR TwinsUK LMU cohort
N (%) 1,741 503 368 286
Age (years) / 60.9 (8.89) 52.5 (7.33) 60.6 (8.04)
Age (10 yrs) 5.7 (1.36)
Male (%) 48.8 62 0 52.4
BMI (kg/m2) 28.1 (4.68) 26.6 (3.89) 26.6 (4.67) NA
current/former/never smoker (%) 15 / 41 / 44 32 / 31 / 37 10 / 38 / 52 22 / 0 / 61
fasting (%) 99.5 29 NA 100
CRP mg/L* 1.25 (0.62–2.47) 1.07 (0.49–2.19) 1.57 (0.72–3.37) 0.4 (0.2–0.98)
Data with normal and skewed distribution (indicated by *) are given as mean (SD) and median (interquartile range) of the variables.
doi:10.1371/journal.pone.0166015.t003
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fragmentation and application of the samples the arrays were fluorescently stained and
scanned. Beta values representing the percentage of DNA methylation of a cytosine were calcu-
lated as the ratio of the methylated signal over the sum of the methylated and unmethylated
signals. Further details on DNA methylation measurement, data preprocessing, and quality
assessments of the four studies are presented in File D in S1 File. Annotations are based on
UCSCGenome Browser on Human Feb. 2009 (GRCh37/hg19) Assembly (https://genome.
ucsc.edu/).
Replication in the LMU liver cohort samples was carried out by MALDI-TOFmass spec-
trometry using EpiTYPER by MassARRAY (Sequenom, San Diego, CA)[48]. Four amplicons
covering 26 CpG sites were selected. Target regions were amplified at 58°C using the prime
pairs described in Table D in S1 File. The chip was read by SequenomMALDI-TOFMS Com-
pact Unit and visualized using MassARRAY EpiTyper v1.2 software (Sequenom). Beta values
were determined by comparing the signal intensities between the mass signals of methylated
and non-methylated templates.
Assessment of gene expression data
In order to assess cell type and tissue specificity of the validated results we generated gene
expression panels in which we quantified the expression of AQP3 and SOCS3 in different
human tissues and blood cell types. Primers and probes for quantitative PCRs (qPCRs) of
AQP3 and SOCS3 are given in Table E in S1 File. Total RNA (1 μg) from human liver, brain,
heart, lung, kidney, small intestine, adipose tissue, skeletal muscle, peripheral bloodmononu-
clear cells (PBMC), CD14-, CD19-, CD3-, CD4-, CD8-positive cells, and regulatory T-cells
(pool of 2–3 donors; Clontech) was reverse transcribed and qPCRs were performed in quadru-
plicate as described[49].Absolute copies were determined using plasmid standard curves and
normalized to μg input RNA. RNA from human livers (n = 304; HTCR Stiftung[50]) was iso-
lated with TRIzol according to the manufacturer’s instructions and 2 μg RNA was reverse tran-
scribed according to published protocols[49]. Normalization was performed using house-
keeping gene expression of ACTB and GAPDH[49]. Subjects with DNA methylation data and
data on CRP concentrations 10 mg/L were included (n = 286).
Statistical analyses
Discovery analysis. In KORA F4 analysis natural log-transformed concentrations of CRP
were modeled using linear mixed effectsmodels with DNA methylation beta values, age, sex,
BMI, fasting status (two categories: fasting for> 8 hours /non-fasting), and cigarette smoking
(ever/former/never smoker) as fixed effects and technical variables (plate and position on
plate) as random effects. In addition, because peripheral blood constitutes a heterogeneous
admixture of different cell types which may be methylated in a cell-type specific way principal
components of white blood cell components estimates[47] were added as fixed effects to adjust
for cell type confounding.
Sensitivity analyses. Sensitivity analyses with various degrees of adjustment were per-
formed and the following covariates were added to the statistical model: lipids (lipid ratio
defined as total cholesterol levels divided by high-density lipoprotein cholesterol, triglycerides,
and low-density lipoprotein cholesterol), uric acid, leptin, fasting glucose, alcohol consumption
[g/day], systolic blood pressure, or systemic hormone therapy (yes/no/male) and other medica-
tion including, regular intake of corticoids or non-steroidal anti-inflammatory drugs, antidia-
beticmedication, intake of antihypertensive and lipid lowering drugs (yes/no).
In addition, effectmodifications by sex were assessed by adding an interaction term in the
multivariate models.
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To control for genomic confounding, correlations betweenCRP related CpG sites identified
in the KORA F4 discovery sample and SNPs with minor allele frequency> 0.05 were assessed
using genomic data previously acquired in the KORA F4 study (File B in S1 File). Subsequently,
for CpG sites which were correlated with one or more common sequence variants (correlation
coefficient 0.8) the analysis was repeated, this time including principal components derived
from the correlated SNPs in the multivariate linear mixed effectsmodels.
Enrichment analyses. All CpG sites which were significant at a false discovery rate level in
the KORA F4 study were included in pathway analyses. Pathway analyses were performed
using the Ingenuity Pathway Analyses (IPA) software tool (IPA build version 338830M, con-
tent version: 23814503, release date 2015-03-23, analysis date 2015-04-20; http://www.
ingenuity.com/). Gene enrichment in canonical pathways was assessed in the core analysis
module using Fisher’s exact test right tailed with Benjamini-Hochberg corrected level of
significance.
Validation analyses. To replicate the findings in another study using DNA methylation
data from peripheral blood, we assessed the association betweenCRP concentrations and
methylation beta values of significant CpG sites in the EPICOR study using the statistical
model of the discovery analysis. Study center reflecting the fasting state of participants was
used as proxy for fasting status.
To assess tissue specificity of the discovery findings results were also assessed in the Twin-
sUK study and the LMU liver cohort. In TwinsUK, all subjects were female and some subjects
were twin pairs. Therefore, sex was not a covariate but family and zygosity were included as
random effects in the model. Furthermore, CRP concentrations were not measured at the time
of DNA extraction and the difference in years betweenmeasurements was used as fixed effect
covariate. TwinsUK data analysis also considered other covariates such as age, BMI, and smok-
ing status (ever/former/never smoker) as fixed effects and technical covariates (plate, bisulfite
conversion levels and bisulfite conversion efficiency) as random effects. For the analysis in the
LMU liver cohort, natural log-transformed levels of CRP were modeled in a linear model using
DNA methylation beta values, 10 years age groups, sex, smoking (yes/no), experimental plate,
information on chemotherapy (yes/no), and indication of surgery (metastasis of hepatocellular,
cholangiocellular or colorectal carcinomas; other metastasis; benign liver tumor; other) as
covariates in the model.
Gene expression analyses. Correlations between normalized transcript levels of AQP3
and SOCS3 and CRP as well as between normalized transcript levels of AQP3 and SOCS3 and
CpG sites of corresponding amplicons were assessed using Spearman’s rank correlation
coefficient.
Multiple testing. Results were corrected for multiple testing and thresholds of significance
were adapted according to Bonferroni in all four studies. P-values below 1.13E-07 (KORA F4),
1.25E-02 (EPICOR and TwinsUK), and 1.92E-03 (LMU liver cohort) were considered
significant.
All statistical analyses were carried out using the software R version 3.0.2 (http://www.r-
project.org/).
Supporting Information
S1 File. SupplementaryMaterial. File A in S1 File. Significant associations (Benjamini Hoch-
berg corrected) betweenCRP and DNA methylation sites in the KORA F4 discovery study. File
B in S1 File. Study Populations. File C in S1 File. Measurement of CRP. File D in S1 File.
Assessment of DNA methylation data in KORA F4, EPICOR, and TwinsUK using the Illumina
HumanMethylation450 BeadChip. Table A in S1 File. Associations betweenCRP and DNA
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methylation sites in the KORA F4 discovery study (n = 1741) after additional adjustments.
Table B in S1 File. Significant associations (Benjamini Hochberg corrected) betweenCRP and
DNA methylation sites in the KORA F4 discovery study. Table C in S1 File. Associations
betweenCRP and DNA methylation sites in the LMU liver cohort. Table D in S1 File.
Sequences of PCR tagged primers used for EpiTYPERmethylation analysis, product size of
each amplicon, and informative CpG sites per amplicon. Table E in S1 File. Primers and probes
for quantitative PCRs. Figure A in S1 File. Expression of AQP3 and SOCS3 (normalized to μg
input RNA) in different human tissues (human brain, heart, lung, kidney, small intestine, adi-
pose tissue, skeletal muscle) and blood cell types (peripheral bloodmononuclear cells (PBMC),
CD14-, CD19-, CD3-, CD4-, CD8-positive cells, and regulatory T-cells).
(DOCX)
Acknowledgments
The authors are grateful to all members of the Helmholtz ZentrumMünchen, the field staff in
Augsburg, and the Augsburg registry team who were involved in the planning, organization,
and conduct of the KORA studies as well as to Mrs Gerlinde Trischler from the Biomarker Lab-
oratory of the Department of Internal Medicine II at the University of UlmMedical Center for
expert technical assistance. In addition, the authors wish to thank all who collaborated with
EPICOR and the Italian AVIS blood donor organization.
Finally, the authors express their appreciation to all study participants.
Author Contributions
Conceptualization:CMHGMWWK.
Data curation: PW SWAKGF SG SP VK RT LI CS GM CM.
Formal analysis:CMGF PCT PW LMHDT.
Funding acquisition:AP CGMWHGWK SP VK RT LI CS GM JTB TDS.
Investigation: CM.
Methodology:CM LMHDT.
Project administration: JTB TDS.
Resources:WKAP BT HGMWHP KS CG SP VK RT LI CS GM LMHDT SLWET TDS JTB.
Supervision:LMHDTWET SL JTB TDSMWHGWK.
Validation: CM PCT.
Visualization: CM LMH.
Writing – original draft:CM.
Writing – review& editing:CM JTB PCT LMHHG BT APMWWK.
References
1. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. (1999) C-Reactive protein, a sen-
sitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-
aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease)
Augsburg Cohort Study, 1984 to 1992. Circulation 99: 237–242. PMID: 9892589
Epigenetic Profiles of CRP in Various Tissues
PLOS ONE | DOI:10.1371/journal.pone.0166015 November 8, 2016 11 / 14
2. Marzi C, Huth C, Herder C, Baumert J, Thorand B, Rathmann W, et al. (2013) Acute-phase serum
amyloid A protein and its implication in the development of type 2 diabetes in the KORA S4/F4 study.
Diabetes Care 36: 1321–1326. doi: 10.2337/dc12-1514 PMID: 23238662
3. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539–545. doi:
10.1016/S0140-6736(00)04046-0 PMID: 11229684
4. Arnaud C, Burger F, Steffens S, Veillard NR, Nguyen TH, Trono D, et al. (2005) Statins reduce interleu-
kin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory
effects of statins. Arterioscler Thromb Vasc Biol 25: 1231–1236. doi: 10.1161/01.ATV.0000163840.
63685.0c PMID: 15790934
5. Black S, Kushner I, Samols D (2004) C-reactive Protein. J Biol Chem 279: 48487–48490. doi: 10.
1074/jbc.R400025200 PMID: 15337754
6. MacGregor AJ, Gallimore JR, Spector TD, Pepys MB (2004) Genetic effects on baseline values of C-
reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins. Clin
Chem 50: 130–134. doi: 10.1373/clinchem.2003.028258 PMID: 14633907
7. Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, et al. (2011) Meta-analysis of genome-
wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circu-
lation 123: 731–738. doi: 10.1161/CIRCULATIONAHA.110.948570 PMID: 21300955
8. Waterland RA, Michels KB (2007) Epigenetic epidemiology of the developmental origins hypothesis.
Annu Rev Nutr 27: 363–388. doi: 10.1146/annurev.nutr.27.061406.093705 PMID: 17465856
9. Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, Lindholm B, et al. (2007) Impact of
inflammation on epigenetic DNA methylation—a novel risk factor for cardiovascular disease? J Intern
Med 261: 488–499. doi: 10.1111/j.1365-2796.2007.01777.x PMID: 17444888
10. Bell JT, Tsai PC, Yang TP, Pidsley R, Nisbet J, Glass D, et al. (2012) Epigenome-wide scans identify
differentially methylated regions for age and age-related phenotypes in a healthy ageing population.
PLOS Genet 8: e1002629. doi: 10.1371/journal.pgen.1002629 PMID: 22532803
11. Gentilini D, Mari D, Castaldi D, Remondini D, Ogliari G, Ostan R, et al. (2013) Role of epigenetics in
human aging and longevity: genome-wide DNA methylation profile in centenarians and centenarians’
offspring. Age (Dordr) 35: 1961–1973.
12. Fuke C, Shimabukuro M, Petronis A, Sugimoto J, Oda T, Miura K, et al. (2004) Age related changes in
5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann
Hum Genet 68: 196–204. doi: 10.1046/j.1529-8817.2004.00081.x PMID: 15180700
13. El-Maarri O, Becker T, Junen J, Manzoor SS, Diaz-Lacava A, Schwaab R, et al. (2007) Gender specific
differences in levels of DNA methylation at selected loci from human total blood: a tendency toward
higher methylation levels in males. Human Genetics 122: 505–514. doi: 10.1007/s00439-007-0430-3
PMID: 17851693
14. Sarter B, Long TL, Tsong WH, Koh WP, Yu MC, Laird PW (2005) Sex differential in methylation pat-
terns of selected genes in Singapore Chinese. Human Genetics 117: 402–403. doi: 10.1007/s00439-
005-1317-9 PMID: 15928902
15. Anderson OS, Sant KE, Dolinoy DC (2012) Nutrition and epigenetics: an interplay of dietary methyl
donors, one-carbon metabolism and DNA methylation. J Nutr Biochem 23: 853–859. doi: 10.1016/j.
jnutbio.2012.03.003 PMID: 22749138
16. Zeilinger S, Kuhnel B, Klopp N, Baurecht H, Kleinschmidt A, Gieger C, et al. (2013) Tobacco smoking
leads to extensive genome-wide changes in DNA methylation. PLOS ONE 8: e63812. doi: 10.1371/
journal.pone.0063812 PMID: 23691101
17. Kerkel K, Spadola A, Yuan E, Kosek J, Jiang L, Hod E, et al. (2008) Genomic surveys by methylation-
sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet 40:
904–908. doi: 10.1038/ng.174 PMID: 18568024
18. Bell JT, Pai AA, Pickrell JK, Gaffney DJ, Pique-Regi R, Degner JF, et al. (2011) DNA methylation pat-
terns associate with genetic and gene expression variation in HapMap cell lines. Genome Biol 12:
R10. doi: 10.1186/gb-2011-12-1-r10 PMID: 21251332
19. Karsli-Ceppioglu S, Dagdemir A, Judes G, Ngollo M, Penault-Llorca F, Pajon A, et al. (2014) Epige-
netic mechanisms of breast cancer: an update of the current knowledge. Epigenomics 6: 651–664.
doi: 10.2217/epi.14.59 PMID: 25531258
20. Grimaldi V, Vietri MT, Schiano C, Picascia A, De Pascale MR, Fiorito C, et al. (2015) Epigenetic repro-
gramming in atherosclerosis. Curr Atheroscler Rep 17: 476. doi: 10.1007/s11883-014-0476-3 PMID:
25433555
21. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420: 860–867. doi: 10.1038/
nature01322 PMID: 12490959
Epigenetic Profiles of CRP in Various Tissues
PLOS ONE | DOI:10.1371/journal.pone.0166015 November 8, 2016 12 / 14
22. Libby P (2002) Inflammation in atherosclerosis. Nature 420: 868–874. doi: 10.1038/nature01323
PMID: 12490960
23. Ballestar E (2011) Epigenetic alterations in autoimmune rheumatic diseases. Nat Rev Rheumatol 7:
263–271. doi: 10.1038/nrrheum.2011.16 PMID: 21343899
24. Durham A, Chou PC, Kirkham P, Adcock IM (2010) Epigenetics in asthma and other inflammatory lung
diseases. Epigenomics 2: 523–537. doi: 10.2217/epi.10.27 PMID: 22121972
25. Burrell AM, Handel AE, Ramagopalan SV, Ebers GC, Morahan JM (2011) Epigenetic mechanisms in
multiple sclerosis and the major histocompatibility complex (MHC). Discov Med 11: 187–196. PMID:
21447278
26. Ho SM (2010) Environmental epigenetics of asthma: an update. J Allergy Clin Immunol 126: 453–465.
doi: 10.1016/j.jaci.2010.07.030 PMID: 20816181
27. Kucukali CI, Kurtuncu M, Coban A, Cebi M, Tuzun E (2014) Epigenetics of Multiple Sclerosis: An
Updated Review. Neuromolecular Med.
28. Wang X, Zhu H, Snieder H, Su S, Munn D, Harshfield G, et al. (2010) Obesity related methylation
changes in DNA of peripheral blood leukocytes. BMC Med 8: 87. doi: 10.1186/1741-7015-8-87 PMID:
21176133
29. Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H (2011) Tobacco-smoking-related differential
DNA methylation: 27K discovery and replication. Am J Hum Genet 88: 450–457. doi: 10.1016/j.ajhg.
2011.03.003 PMID: 21457905
30. Joubert BR, Haberg SE, Nilsen RM, Wang X, Vollset SE, Murphy SK, et al. (2012) 450K epigenome-
wide scan identifies differential DNA methylation in newborns related to maternal smoking during preg-
nancy. Environ Health Perspect 120: 1425–1431. doi: 10.1289/ehp.1205412 PMID: 22851337
31. Sun YV, Lazarus A, Smith JA, Chuang YH, Zhao W, Turner ST, et al. (2013) Gene-specific DNA meth-
ylation association with serum levels of C-reactive protein in African Americans. PLOS ONE 8:
e73480. doi: 10.1371/journal.pone.0073480 PMID: 23977389
32. Aaronson DS, Horvath CM (2002) A road map for those who don’t know JAK-STAT. Science 296:
1653–1655. doi: 10.1126/science.1071545 PMID: 12040185
33. Kiu H, Nicholson SE (2012) Biology and significance of the JAK/STAT signalling pathways. Growth
Factors 30: 88–106. doi: 10.3109/08977194.2012.660936 PMID: 22339650
34. Hara-Chikuma M, Verkman AS (2008) Aquaporin-3 facilitates epidermal cell migration and proliferation
during wound healing. J Mol Med (Berl) 86: 221–231.
35. Marchini G, Stabi B, Kankes K, Lonne-Rahm S, Ostergaard M, Nielsen S (2003) AQP1 and AQP3,
psoriasin, and nitric oxide synthases 1–3 are inflammatory mediators in erythema toxicum neona-
torum. Pediatr Dermatol 20: 377–384. PMID: 14521551
36. Tancharoen S, Matsuyama T, Abeyama K, Matsushita K, Kawahara K, Sangalungkarn V, et al. (2008)
The role of water channel aquaporin 3 in the mechanism of TNF-alpha-mediated proinflammatory
events: Implication in periodontal inflammation. J Cell Physiol 217: 338–349. doi: 10.1002/jcp.21506
PMID: 18543247
37. Mei WX, Lao SX, Yu N, Zhou Z, Huang LP, Hu B (2010) Relationship between gene expressions of
aquaporin 3 and 4 and various degrees of spleen-stomach dampness-heat syndrome in chronic super-
ficial gastritis. Zhong Xi Yi Jie He Xue Bao 8: 111–115. PMID: 20141731
38. Nakahigashi K, Kabashima K, Ikoma A, Verkman AS, Miyachi Y, Hara-Chikuma M (2011) Upregulation
of aquaporin-3 is involved in keratinocyte proliferation and epidermal hyperplasia. J Invest Dermatol
131: 865–873. doi: 10.1038/jid.2010.395 PMID: 21191421
39. Horie I, Maeda M, Yokoyama S, Hisatsune A, Katsuki H, Miyata T, et al. (2009) Tumor necrosis factor-
alpha decreases aquaporin-3 expression in DJM-1 keratinocytes. Biochem Biophys Res Commun
387: 564–568. doi: 10.1016/j.bbrc.2009.07.077 PMID: 19619514
40. Molavi O, Wang P, Zak Z, Gelebart P, Belch A, Lai R (2013) Gene methylation and silencing of SOCS3
in mantle cell lymphoma. Br J Haematol 161: 348–356. doi: 10.1111/bjh.12262 PMID: 23432547
41. Wang J, Zhou H, Han Y, Liu X, Wang M, Wang X, et al. (2014) SOCS3 methylation in synergy with
Reg3A overexpression promotes cell growth in pancreatic cancer. J Mol Med (Berl) 92: 1257–1269.
42. Isomoto H, Mott JL, Kobayashi S, Werneburg NW, Bronk SF, Haan S, et al. (2007) Sustained IL-6/
STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing. Gastroenterology
132: 384–396. doi: 10.1053/j.gastro.2006.10.037 PMID: 17241887
43. Niwa Y, Kanda H, Shikauchi Y, Saiura A, Matsubara K, Kitagawa T, et al. (2005) Methylation silencing
of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human
hepatocellular carcinoma. Oncogene 24: 6406–6417. doi: 10.1038/sj.onc.1208788 PMID: 16007195
Epigenetic Profiles of CRP in Various Tissues
PLOS ONE | DOI:10.1371/journal.pone.0166015 November 8, 2016 13 / 14
44. Tischoff I, Hengge UR, Vieth M, Ell C, Stolte M, Weber A, et al. (2007) Methylation of SOCS-3 and
SOCS-1 in the carcinogenesis of Barrett’s adenocarcinoma. Gut 56: 1047–1053. doi: 10.1136/gut.
2006.111633 PMID: 17376806
45. Pierconti F, Martini M, Pinto F, Cenci T, Capodimonti S, Calarco A, et al. (2011) Epigenetic silencing of
SOCS3 identifies a subset of prostate cancer with an aggressive behavior. Prostate 71: 318–325. doi:
10.1002/pros.21245 PMID: 20717995
46. Jaffe AE, Irizarry RA (2014) Accounting for cellular heterogeneity is critical in epigenome-wide associa-
tion studies. Genome Biol 15: R31. doi: 10.1186/gb-2014-15-2-r31 PMID: 24495553
47. Houseman EA, Molitor J, Marsit CJ (2014) Reference-free cell mixture adjustments in analysis of DNA
methylation data. Bioinformatics 30: 1431–1439. doi: 10.1093/bioinformatics/btu029 PMID: 24451622
48. Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, et al. (2005) Quantitative
high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrome-
try. Proc Natl Acad Sci U S A 102: 15785–15790. doi: 10.1073/pnas.0507816102 PMID: 16243968
49. Holdt LM, Hoffmann S, Sass K, Langenberger D, Scholz M, Krohn K, et al. (2013) Alu elements in
ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regu-
lation of gene networks. PLOS Genet 9: e1003588. doi: 10.1371/journal.pgen.1003588 PMID:
23861667
50. Pfeiffer L, Wahl S, Pilling LC, Reischl E, Sandling JK, Kunze S, et al. (2015) DNA methylation of lipid-
related genes affects blood lipid levels. Circ Cardiovasc Genet 8: 334–342. doi: 10.1161/
CIRCGENETICS.114.000804 PMID: 25583993
Epigenetic Profiles of CRP in Various Tissues
PLOS ONE | DOI:10.1371/journal.pone.0166015 November 8, 2016 14 / 14
